Your search returned 115 studies. (Get alerts for new studies):
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Metastatic Cancer
2 Locations available
- Antineoplaston Therapy in Treating Patients With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Children With Visual Pathway Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Study of Individuals and Families at High Risk for Cancer
Conditions: Bladder Cancer - Brain and Central Nervous System Tumors - Chordoma - Lung Cancer - Non-melanomatous Skin Cancer - Retinoblastoma - Sarcoma
2 Locations available
- Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or
Conditions: Brain and Central Nervous System Tumors
3 Locations available
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Na
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Head and Neck Cancer - Lymphoma - Nausea and Vomiting - Neuroblastoma - Ovarian Cancer - Sarcoma
1 Location available
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
126 Locations available
- Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- Proton Nuclear Magnetic Resonance Spectroscopic Imaging Compared With Fludeoxyglucose F 18 Positron Emission Tomography Scanning in Determining Biolog
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Treating Patients With High-Grade Glioma With IA Carboplatin-based Chemotherapy, With or Without Sodium Thiosulfate
Conditions: Brain and Central Nervous System Tumors - Thrombocytopenia
3 Locations available
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastom
Conditions: Brain and Central Nervous System Tumors
167 Locations available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Neuroblastoma - Sarcoma
1 Location available
- Melphalan With BBBD in Treating Patients With Brain Malignancies
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Metastatic Cancer
1 Location available
- Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
Conditions: Brain and Central Nervous System Tumors
3 Locations available
- Rituximab&Methotrexate Chemotherapy w/BBBD & Sodium Thiosulfate Chemoprotection for Patients With Newly Diagnosed PCNSL
Conditions: Brain and Central Nervous System Tumors - Lymphoma
2 Locations available
- Combination Chemotherapy With BBBD Followed By Sodium Thiosulfate in Treating Patients With Anaplastic Oligodendroglioma or Oligoastrocytoma
Conditions: Brain and Central Nervous System Tumors
3 Locations available
- Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
Conditions: Brain and Central Nervous System Tumors
9 Locations available
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
145 Locations available
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroect
Conditions: Brain and Central Nervous System Tumors
102 Locations available
- Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue - Metastatic Cancer - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity
14 Locations available
- Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial
Conditions: Brain and Central Nervous System Tumors
142 Locations available
- Side Effects of Radiation Therapy in Young Patients With CNS Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity
1 Location available
- Enzastaurin and Carboplatin in Treating Patients With Recurrent or Refractory Primary Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Natural History Study of Patients With Central Nervous System Tumors Being Evaluated at the National Institutes of Health
Conditions: Brain and Central Nervous System Tumors - Chordoma - Neuroblastoma
2 Locations available
- Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinic
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Adults - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Metastatic Cancer - Neurofibromatosis Type
1 Location available
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors - Extragonadal Germ Cell Tumor - Ovarian Cancer - Teratoma - Testicular Germ Cell Tumor
2 Locations available
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
245 Locations available
- Studying Patients With a Personal or Family History of Cancer Caused by a Virus
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Sarcoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
1 Location available
- Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors - Neurofibromatosis Type 1 - Neurofibromatosis Type 2 - Precancerous Condition
4 Locations available
- Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma or Ependymoma
Conditions: Brain and Central Nervous System Tumors
4 Locations available
- Dasatinib in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Liver Cancer - Lymphoma - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
9 Locations available
- Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Total Marrow Irradiation Added to an Alkylator-Intense Conditioning Regimen for Patients With High Risk or Relapsed Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Kidney Cancer - Liver Cancer - Retinoblastoma - Sarcoma
1 Location available
- Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid
Conditions: Brain and Central Nervous System Tumors
77 Locations available
- Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pa
1 Location available
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
70 Locations available
- Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects
18 Locations available
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
113 Locations available
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
4 Locations available
- Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Conditions: Brain and Central Nervous System Tumors - Chemotherapeutic Agent Toxicity - Cognitive/Functional Effects - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment - Radiation Toxicity - Therapy-related Toxicity
99 Locations available
- Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery
Conditions: Brain and Central Nervous System Tumors
1 Location available
- GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Vorinostat, Isotretinoin, and Combination Chemotherapy in Treating Young Patients Who Have Undergone Surgery for Embryonal Tumors of the Central Nervo
Conditions: Brain and Central Nervous System Tumors
6 Locations available
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
224 Locations available
- Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Conditions: Brain and Central Nervous System Tumors
69 Locations available
- Study of Stored Tumor Samples in Young Patients With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- Studying Fentanyl in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Pr
1 Location available
- PET Scan Using 18F-Fluoromisonidazole and MRI In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Conditions: Brain and Central Nervous System Tumors
139 Locations available
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Brain and Central Nervous System Tumors - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
19 Locations available
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Un
2 Locations available
- GDC-0449 in Treating Adult Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
6 Locations available
- Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Neuroblastoma - Unspecified Childhood Solid Tumor, Protocol Specific
25 Locations available
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
162 Locations available
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Conditions: Stage IV Breast Cancer - Central Nervous System Involvement/Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Tumors Metastatic to Brain
1 Location available
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
44 Locations available
- Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
113 Locations available
- Study of Blood and Cheek Cell Samples From Patients With Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue
1 Location available
- Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
7 Locations available
- Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck
Conditions: Central Nervous System Tumors
1 Location available
- MEK Inhibitor AZD6244 in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Epend
Conditions: Brain and Central Nervous System Tumors
109 Locations available
- Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (
Conditions: Brain Tumors - Non-CNS Malignancies
1 Location available
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- Cilengitide and Sunitinib Malate in Treating Patients With Advanced Solid Tumors or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
Conditions: Brain and Central Nervous System Tumors
5 Locations available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors - Breast Cancer - Colorectal Cancer - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
Conditions: Brain and Central Nervous System Tumors
15 Locations available
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS P
Conditions: Brain and Central Nervous System Tumors
84 Locations available
- Lenalidomide and Radiation Therapy in Treating Young Patients With Pontine Glioma or High-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
Conditions: Brain and Central Nervous System Tumors - Kidney Cancer - Sarcoma
141 Locations available
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Leukemia - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
22 Locations available
- Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
Conditions: Brain and Central Nervous System Tumors
9 Locations available
- GDC-0449 in Treating Younger Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- O6-Benzylguanine and Temozolomide in Combination With Genetically Modified Peripheral Blood Stem Cells in Treating Patients With Newly Diagnosed Gliob
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent, Progressive, or Newly Diagno
Conditions: Brain and Central Nervous System Tumors - Depression
1 Location available
- Acupressure in Controlling Nausea in Young Patients With Central Nervous System or Solid Tumors Receiving Cisplatin-Containing Chemotherapy
Conditions: Brain and Central Nervous System Tumors - Nausea and Vomiting - Unspecified Childhood Solid Tumor, Protocol Specific
19 Locations available
- Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
Conditions: Brain and Central Nervous System Tumors - Cognitive/Functional Effects - Fatigue - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
9 Locations available
- Natural History of Patients With Brain and Spinal Cord Tumors
Conditions: Astrocytoma - Central Nervous System Tumor - Glioblastoma - Glioma - Medulloblastoma
1 Location available
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Brain and Central Nervous System Tumors
42 Locations available
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
Conditions: Brain and Central Nervous System Tumors - Unspecified Childhood Solid Tumor, Protocol Specific
10 Locations available
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glio
Conditions: Brain and Central Nervous System Tumors - Neurofibromatosis Type 1
18 Locations available
- Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
|